Medical News

RSS

Boston Scientific gains CE Mark, begins European commercial launch of 25 mm Lotus TAVI System

Boston Scientific Corporation has received CE Mark and begun the European commercial launch of its new 25 mm Lotus Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes.

14 Jul 2014

PLI's Health Care Mergers and Acquisitions Answer Book 2014 released

Practising Law Institute announces the release of their newest title, Health Care Mergers and Acquisitions Answer Book 2014. Co-edited by two experts from Debevoise & Plimpton LLP, Andrew L. Bab and Kevin A. Rinker, Health Care Mergers and Acquisitions Answer Book 2014 is a specialized Q&A guide to the legal aspects of health care M&A transactions.

14 Jul 2014

Arrowroot Capital makes $4 million investment in MedNet Solutions

MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Arrowroot Capital, a growth equity firm focused on software-as-a-service (SaaS) and Internet-based businesses, has made a $4 million investment in MedNet Solutions.

14 Jul 2014

NLC awards grants to eight cities to help enroll children, families in Medicaid and CHIP

To help implement local outreach efforts to enroll children and families in Medicaid and the Children's Health Insurance Program, the National League of Cities today awarded grants and technical assistance to eight cities.

14 Jul 2014

Dozens of religious groups refuse to sign contraceptive opt-out form

The two-page form, designed to accommodate religious beliefs, is regarded as an untenable compromise by some religious employers, reports The New York Times. Meanwhile, GOP governors see little fallout from the Supreme Court's contraceptive coverage decision and a poll shows growing Republican support for the court.

14 Jul 2014

Study: Obese firefighters don’t get weight management advice from health care providers

Obese and overweight firefighters are not receiving weight management advice from their health care providers, according to new research from The University of Texas Health Science Center at Houston.

14 Jul 2014

Study pinpoints molecular cause of cachexia, hints at a potential treatment

New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute.

14 Jul 2014

New research opens up potential new therapeutic targets for hard-to-treat food allergy

New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy.

14 Jul 2014

ADSC transplantation promotes adult neurogenesis in brains of Alzheimer's disease mice

Recent evidence has demonstrated that transplantation of mesenchymal stem cells can stimulate neurogenesis in the brain of adult rat or mouse models of Alzheimer's disease (AD) and improve tissue and function injury under the condition of cerebral ischemia.

14 Jul 2014

Resarchers offer insight into how low-wage jobs affect public health, economy in Syracuse, N.Y.

As low-wage jobs continue to show strong gains since the recession, findings from the Low-Wage Workers' Health Project led by Upstate Medical University is offering insight into how these jobs affect public health and the economy in Syracuse, N.Y., and reflect national trends in issues related to low-wage workers.

14 Jul 2014

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration has approved Rasuvo, a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector for rheumatoid arthritis (RA), polyarticular-course juvenile idiopathic arthritis (pJIA) and psoriasis.

14 Jul 2014

Sunscreens do not protect totally against development of skin cancer, shows study

The researcher at the Neurosciences Institute, Joint Center of the University Miguel Hernández (UMH) in Elche and the Higher Council for Scientific Research (CSIC), Berta López Sánchez-Laorden co-authored a study that concluded that sunscreens do not protect totally against the development of skin cancer.

14 Jul 2014

Pareto partners with DNA2.0 to develop technology for quick-to-market products

Synthetic biology company Pareto Biotechnologies today announces a technology partnership with global bioengineering leader DNA2.0, enabling Pareto to further develop its technology for quick-to-market products.

14 Jul 2014

First Edition: July 14, 2014

Today's headlines include coverage of Medicare, the health law and veterans' care policy issues as well as reports from the campaign trail.

14 Jul 2014

New genetic programs for taking blank-slate stem cells and turning them into human blood

The ability to reliably and safely make in the laboratory all of the different types of cells in human blood is one key step closer to reality.

14 Jul 2014

Mylan enters into definitive agreement to acquire Abbott's branded generics pharmaceuticals business

Mylan Inc. today announced that it has entered into a definitive agreement with Abbott whereby Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business ("the Assets") in an all-stock transaction.

14 Jul 2014

Rates of testicular cancer rise in recent years among young Hispanic American men

A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.

14 Jul 2014

Improving type 2 diabetes management: an interview with Sir Michael Hirst, President of the International Diabetes Federation

One study suggested that 42 percent of people with type 2 diabetes who are treated for the disease do not reach their blood sugar goals, putting them at higher risk of organ and tissue damage, blindness and even death. We wanted to explore potential causes of clinical inertia among physicians and people with diabetes, which may lead to sub-optimal care.

14 Jul 2014

MGC Diagnostics completes stock purchase agreement to acquire Medisoft SA

MGC Diagnostics Corporation, a leading global medical technologies company, today announced that it has completed a stock purchase agreement to acquire Medisoft SA, a Sorinnes, Belgium headquartered, privately held manufacturer of market-leading cardiorespiratory diagnostic products.

14 Jul 2014

'Pure mass of HES molecules' explains toxicity to renal tubule cells

The increased risk of kidney injury related to the use of hydroxyethyl starch (HES) in resuscitation fluids reflects the mass of HES molecules, according to a report in Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

14 Jul 2014

Medical News

Boston Scientific gains CE Mark, begins European commercial launch of 25 mm Lotus TAVI System

PLI's Health Care Mergers and Acquisitions Answer Book 2014 released

Arrowroot Capital makes $4 million investment in MedNet Solutions

NLC awards grants to eight cities to help enroll children, families in Medicaid and CHIP

Dozens of religious groups refuse to sign contraceptive opt-out form

Study: Obese firefighters don’t get weight management advice from health care providers

Study pinpoints molecular cause of cachexia, hints at a potential treatment

New research opens up potential new therapeutic targets for hard-to-treat food allergy

ADSC transplantation promotes adult neurogenesis in brains of Alzheimer's disease mice

Resarchers offer insight into how low-wage jobs affect public health, economy in Syracuse, N.Y.

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Sunscreens do not protect totally against development of skin cancer, shows study

Pareto partners with DNA2.0 to develop technology for quick-to-market products

First Edition: July 14, 2014

New genetic programs for taking blank-slate stem cells and turning them into human blood

Mylan enters into definitive agreement to acquire Abbott's branded generics pharmaceuticals business

Rates of testicular cancer rise in recent years among young Hispanic American men

Improving type 2 diabetes management: an interview with Sir Michael Hirst, President of the International Diabetes Federation

MGC Diagnostics completes stock purchase agreement to acquire Medisoft SA

'Pure mass of HES molecules' explains toxicity to renal tubule cells

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News